Does AFLIBERCEPT Cause Product dose omission issue? 1,051 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,051 reports of Product dose omission issue have been filed in association with AFLIBERCEPT (EYLEA). This represents 3.9% of all adverse event reports for AFLIBERCEPT.
1,051
Reports of Product dose omission issue with AFLIBERCEPT
3.9%
of all AFLIBERCEPT reports
4
Deaths
40
Hospitalizations
How Dangerous Is Product dose omission issue From AFLIBERCEPT?
Of the 1,051 reports, 4 (0.4%) resulted in death, 40 (3.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AFLIBERCEPT. However, 1,051 reports have been filed with the FAERS database.
What Other Side Effects Does AFLIBERCEPT Cause?
Death (7,669)
Visual impairment (1,836)
Blindness (1,337)
Endophthalmitis (1,289)
Off label use (1,156)
Eye pain (1,057)
Blindness unilateral (1,012)
Vision blurred (1,012)
Visual acuity reduced (993)
Blindness transient (987)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which AFLIBERCEPT Alternatives Have Lower Product dose omission issue Risk?
AFLIBERCEPT vs AGALSIDASE ALFA
AFLIBERCEPT vs AGALSIDASE BETA
AFLIBERCEPT vs AGOMELATINE
AFLIBERCEPT vs ALAWAY
AFLIBERCEPT vs ALBENDAZOLE